BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3948157)

  • 1. Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay.
    Manni A; Wright C; Davis G; Glenn J; Joehl R; Feil P
    Cancer Res; 1986 Apr; 46(4 Pt 1):1669-72. PubMed ID: 3948157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay.
    Manni A; Wright C; Pontari M; Feil P; Joehl R
    J Natl Cancer Inst; 1985 Apr; 74(4):767-70. PubMed ID: 2985856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway.
    Manni A; Badger B; Wright C; Ahmed SR; Demers LM
    Cancer Res; 1987 Jun; 47(12):3066-71. PubMed ID: 3107802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine stimulation by estradiol-regulated growth factors of rat hormone-responsive mammary cancer: interaction with the polyamine pathway.
    Manni A; Wright C; Feil P; Baranao L; Demers L; Garcia M; Rochefort H
    Cancer Res; 1986 Apr; 46(4 Pt 1):1594-8. PubMed ID: 3081252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth enhancement of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar by estrogen or prolactin.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1984 Dec; 44(12 Pt 1):5605-8. PubMed ID: 6498820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
    Leroy-Martin B; Peyrat JP
    Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol receptor levels in human breast carcinomas.
    Bird CE; Houghton B; Westenbrink W; Tenniswood M; Sterns EE; Clark AF
    Can Med Assoc J; 1981 Apr; 124(8):1010-2. PubMed ID: 7260784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro growth characteristics and chemosensitivities of endometrial cancer using a soft agar clonogenic assay.
    Jones CM; Welander CE; Berens ME; Homesley HD
    Obstet Gynecol; 1987 Feb; 69(2):237-41. PubMed ID: 3808509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro chemosensitivity of urological malignancies evaluated by colony-forming assay using soft agar].
    Yamamoto N
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1573-81. PubMed ID: 4040734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH; Miller KK; Schuler LA
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar.
    Manni A; Wright C; Buck H
    Breast Cancer Res Treat; 1991 Dec; 20(1):43-52. PubMed ID: 1813068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.
    Biswas R; Vonderhaar BK
    Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone-dependency of human breast cancer in in vitro clonogenic assay].
    Nomura Y; Tashiro H; Takaekoh F; Hisamatsu K
    Gan No Rinsho; 1987 Feb; 33(2):153-8. PubMed ID: 3560449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Soft agar culture of human prostatic carcinoma--effect of testosterone on the clonal growth of the cells].
    Sakuramoto T; Kubota Y; Kitajima N; Hosaka M
    Hinyokika Kiyo; 1985 Oct; 31(10):1717-21. PubMed ID: 4091120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.